Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Barhemsys for PONV Combination Prophylaxis
NCT02337062Phase 3Completed
- Sponsor
- Acacia Pharma Group Plc
- Start
- Feb 2015
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial in Nausea and Vomiting comparing Barhemsys + standard anti-emetic with Placebo + standard anti-emetic (2 arms). Primary endpoint: Complete Response at 24 hours. Started Feb 2015; status: completed.
02
Drugs
amisulpride
03
Conditions
Nausea and Vomiting
Beyond the preview
Go deeper on NCT02337062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02337062.